Header Logo

Connection

Shama Khan to Molecular Dynamics Simulation

This is a "connection" page, showing publications Shama Khan has written about Molecular Dynamics Simulation.
Connection Strength

2,179
  1. Targeting ebola virus VP40 protein through novel inhibitors: exploring the structural and dynamic perspectives on molecular landscapes. J Mol Model. 2021 Jan 25; 27(2):49.
    View in: PubMed
    Score: 0,726
  2. Discovering potential inhibitors of Raf proto-oncogene serine/threonine kinase 1: a virtual screening approach towards anticancer drug development. J Biomol Struct Dyn. 2024 Feb-Mar; 42(4):1846-1857.
    View in: PubMed
    Score: 0,212
  3. Structure-based identification of potential SARS-CoV-2 main protease inhibitors. J Biomol Struct Dyn. 2022 05; 40(8):3595-3608.
    View in: PubMed
    Score: 0,179
  4. Selective Covalent Inhibition of "Allosteric Cys121" Distort the Binding of PTP1B Enzyme: A Novel Therapeutic Approach for Cancer Treatment. Cell Biochem Biophys. 2019 Sep; 77(3):203-211.
    View in: PubMed
    Score: 0,164
  5. Exploring the Structural Mechanism of Covalently Bound E3 Ubiquitin Ligase: Catalytic or Allosteric Inhibition? Protein J. 2018 12; 37(6):500-509.
    View in: PubMed
    Score: 0,156
  6. Covalent simulations of covalent/irreversible enzyme inhibition in drug discovery: a reliable technical protocol. Future Med Chem. 2018 10; 10(19):2265-2275.
    View in: PubMed
    Score: 0,154
  7. Reversible versus irreversible inhibition modes of ERK2: a comparative analysis for ERK2 protein kinase in cancer therapy. Future Med Chem. 2018 05 01; 10(9):1003-1015.
    View in: PubMed
    Score: 0,149
  8. Classification and Functional Analyses of Putative Conserved Proteins from Chlamydophila pneumoniae CWL029. Interdiscip Sci. 2017 Mar; 9(1):96-106.
    View in: PubMed
    Score: 0,127
  9. Thymoquinone, artemisinin, and thymol attenuate proliferation of lung cancer cells as Sphingosine kinase 1 inhibitors. Biomed Pharmacother. 2024 Aug; 177:117123.
    View in: PubMed
    Score: 0,058
  10. MAP/Microtubule Affinity Regulating Kinase 4 Inhibitory Potential of Irisin: A New Therapeutic Strategy to Combat Cancer and Alzheimer's Disease. Int J Mol Sci. 2021 Oct 12; 22(20).
    View in: PubMed
    Score: 0,048
  11. Impact of single amino acid substitution on the structure and function of TANK-binding kinase-1. J Cell Biochem. 2021 10; 122(10):1475-1490.
    View in: PubMed
    Score: 0,047
  12. Structure-based investigation of MARK4 inhibitory potential of Naringenin for therapeutic management of cancer and neurodegenerative diseases. J Cell Biochem. 2021 10; 122(10):1445-1459.
    View in: PubMed
    Score: 0,047
  13. Tracing Potential Covalent Inhibitors of an E3 Ubiquitin Ligase through Target-Focused Modelling. Molecules. 2019 Aug 28; 24(17).
    View in: PubMed
    Score: 0,041
  14. Distinguishing the optimal binding mechanism of an E3 ubiquitin ligase: Covalent versus noncovalent inhibition. J Cell Biochem. 2019 08; 120(8):12859-12869.
    View in: PubMed
    Score: 0,040
  15. PKR-inhibitor binds efficiently with human microtubule affinity-regulating kinase 4. J Mol Graph Model. 2015 Nov; 62:245-252.
    View in: PubMed
    Score: 0,031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.